Business
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
Boca Raton, Florida, May 05, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s Disease (AD), today announced that it will host a conference call on Thursday, May 8th, 2025 at 4:30pm EDT to discuss results for its quarter ended March 31, 2025 and to provide a corporate update. Conference Call Information To participate in this event, dial appr
About this update from Inmune Bio Inc.
[{"type":"image","alt":"INmune Bio, Inc.","displaySize":"","headline":null,"caption":"INmune Bio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":82,"height":60,"url":"https://media.zenfs.com/en/globenewswire.com/b1e094e63c3b156eab453d7533cada9b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ESFQnG17m_59Q1hSBmvAug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b1e094e63c3b156eab453d7533cada9b","width":82,"height":60}},"lazy":false},{"type":"text","content":"Boca Raton, Florida, May 05, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s Disease (AD), today announced that it will host a conference call on Thursday, May 8th, 2025 at 4:30pm EDT to discuss results for its quarter ended March 31, 2025 and to provide a corporate update.","length":438,"tagName":"p"},{"type":"text","content":"Conference Call Information","length":27,"tagName":"p"},{"type":"text","content":"To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Please ask for the INmune Bio First Quarter Conference Call when reaching the operator.","length":186,"tagName":"p"},{"type":"text","content":"Date: May 8th, 2025","length":19,"tagName":"p"},{"type":"text","content":"Time: 4:30 PM Eastern Time","length":26,"tagName":"p"},{"type":"text","content":"Participant Dial-in: 1-800-267-6316 Participant Dial-in (international): +1-203-518-9783","length":88,"tagName":"p"},{"type":"text","content":"Conference ID: INMUNE","length":21,"tagName":"p"},{"type":"text","content":"A live audio webcast of the call can be accessed by clicking here or using this link:","length":85,"tagName":"p"},{"type":"text","content":"https://viavid.webcasts.com/starthere.jsp?ei=1712673&tp_key=b29f89f7f9","length":74,"tagName":"p"},{"type":"text","content":"A transcript will follow approximately 24 hours from the scheduled call. A replay will also be available through May 22nd, 2025 by dialing 1-844-512-2921 or 1-412-317-6671 (international) and entering pin no. 11158539.","length":218,"tagName":"p"},{"type":"text","content":"About INmune Bio Inc.","length":21,"tagName":"p"},{"type":"text","content":"INmune Bio Inc. is a publicly traded (N...